{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:26:38Z","timestamp":1779888398330,"version":"3.53.1"},"reference-count":72,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold>Chronic hepatitis C (CHC) is a significant cause of liver related morbidity and mortality worldwide. The role of genetics in the host response to hepatitis C virus is not elucidated. Genetic variations in<jats:italic>UGT1A1<\/jats:italic>gene are the most common cause of hereditary unconjugated hyperbilirubinemia-Gilbert syndrome. This is the first study investigating the association of<jats:italic>UGT1A1<\/jats:italic>TA repeats promoter genotypes with the degree of liver injury, viremia and biochemical markers in CHC patients with advanced liver injury and late virological relapse.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Genetic testing of<jats:italic>UGT1A1<\/jats:italic>TA repeats promoter genotypes was performed in 42 CHC patients with advanced fibrosis and cirrhosis who achieved sustained virological response and 42 healthy blood donors. CHC patients were evaluated for clinical findings, laboratory tests and imaging.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold><jats:italic>UGT1A1<\/jats:italic>*28 genotype (7\/7 TA repeats) was observed in 23.8% CHC patients and 16.7% healthy controls with no significant difference in genotype frequencies (p=0.49). Pretreatment levels of ferritin and bilirubin were associated with the presence of<jats:italic>UGT1A1*28<\/jats:italic>genotype, indicating its potential as a predictive marker. However, in our study, there was no correlation of<jats:italic>UGT1A1*28<\/jats:italic>genotype with the degree of fibrosis or viremia. During antiviral treatment, dose reductions and treatment interruptions, as well as treatment success and occurrence of late virological relapse were not related to the presence of<jats:italic>UGT1A1*28<\/jats:italic>genotype in CHC patients with severe liver injury.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>Frequencies of<jats:italic>UGT1A1*28<\/jats:italic>genotype are high in both Serbian CHC patients and healthy subjects. The presence of<jats:italic>UGT1A1*28<\/jats:italic>genotype was not associated with ribavirin-related adverse effects and had no effect on long term outcome in CHC patients.<\/jats:p>","DOI":"10.2478\/jomb-2018-0015","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T22:16:31Z","timestamp":1525472191000},"page":"45-52","source":"Crossref","is-referenced-by-count":5,"title":["Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused by Chronic Hepatitis C"],"prefix":"10.5937","volume":"38","author":[{"given":"Jelena","family":"Jordovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenija","family":"Bojovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Simonovic-Babic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Kotur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Zukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Lazarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bekic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Uro\u0161evic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Delic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref181","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/jomb-2017-0003","article-title":"Patient and sample identification Out of the maze","volume":"19","author":"Lippi","year":"2017","journal-title":"J Med Biochem"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10147-013-0562-5","article-title":"Association between severe toxicity of nilotinib and polymorphisms in Japanese patients with chronic myelogenous leukemia","volume":"19","author":"Shibata","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"ref751","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/38.9.1853","article-title":"Wagenknecht Sex - and race - related differences in liver - associated serum chemistry tests in young adults in the CARDIA study","volume":"38","author":"Manolio TA","year":"1992","journal-title":"Clin Chem"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"31","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis diagnosis grading staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"ref651","first-page":"1","article-title":"Racial variability in the UDP glucuronosyltransferase promoter a balanced polymorphism for regulation of bilirubin metabolism","volume":"22","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis diagnosis grading staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2478\/jomb-2013-0035","article-title":"Molecular genetic markers as a basis for personalized","volume":"11","author":"Pavlovi\u0107","year":"2014","journal-title":"medicine J Med Biochem"},{"key":"ref761","first-page":"347","article-title":"Genetic variation in bilirubin glucuronosyltransferase gene promoter syndrome","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"ref711","first-page":"405","article-title":"Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium : The Study Viral","volume":"28","author":"Payan","year":"2005"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/jomb-2017-0003","article-title":"Patient and sample identification Out of the maze","volume":"19","author":"Lippi","year":"2017","journal-title":"J Med Biochem"},{"key":"ref721","first-page":"112","article-title":"nekonjugirane hiperbilirubinemije","volume":"29","author":"Jur\u010di\u0107","year":"2006","journal-title":"Paediatr Croat"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1665-2681(19)31774-0","article-title":"TO syndrome of hepatitis","volume":"8","author":"Deterding","year":"2009","journal-title":"antiviral therapy Ann Hepatol"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4254\/wjh.v6.i2.92","article-title":"Association between inherited monogenic liver disorders and chronic hepatitis of","volume":"6","author":"Piekuse","year":"2014","journal-title":"World Journal Hepatology"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-2423(10)50003-9","article-title":"Serum bilirubin levels and cardiovascular disease risk a","volume":"50","author":"Franchini","year":"2010","journal-title":"Adv Clin Chem"},{"key":"ref471","first-page":"142","article-title":"Hereditary hyperbilirubinemias","author":"Radlovi\u0107","year":"2014"},{"key":"ref321","first-page":"347","article-title":"Genetic variation in bilirubin glucuronosyltransferase gene promoter syndrome","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13016","article-title":"Follow - up of patients with chronic hepatitis and a sustained viral response","volume":"16","author":"Serfaty","year":"2016","journal-title":"Liver Int"},{"key":"ref481","first-page":"1","article-title":"da relationship with abnormal total bilirubin levels in chronic hepatitis patients Outcomes from a case - control study","volume":"11","author":"De Souza","year":"2017","journal-title":"Medicine"},{"key":"ref241","first-page":"1","article-title":"hepatitis virusna infekcija In virusni hepatitis st ed Beograd za ud\u017cbenike","volume":"25","author":"Deli\u0107","year":"2012"},{"key":"ref521","first-page":"1","article-title":"Effect of the allele on unconjugated hyperbilirubinemia in HIV - positive patients receiving Atazanavir a systematic","volume":"47","author":"Culley","year":"2013","journal-title":"review Ann Pharmacother"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/clinchem\/46.6.883","article-title":"staining of denaturing gradient gel electrophoresis","volume":"20","author":"Radojkovi\u0107","year":"2000","journal-title":"gels Clin Chem"},{"key":"ref571","first-page":"2015","article-title":"and risk factors for hepatitis virus infection among blood donors in multicentre study Dig","volume":"14","author":"Mitrovi\u0107","journal-title":"Liver Dis"},{"key":"ref681","first-page":"1","article-title":"hepatitis virusna infekcija In virusni hepatitis st ed Beograd za ud\u017cbenike","volume":"25","author":"Deli\u0107","year":"2012"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2008.01.004","article-title":"Environmental factors as disease accelerators during chronic hepatitis of","author":"Mallat","year":"2008","journal-title":"Journal Hepatology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2478\/jomb-2013-0035","article-title":"Molecular genetic markers as a basis for personalized","volume":"11","author":"Pavlovi\u0107","year":"2014","journal-title":"medicine J Med Biochem"},{"key":"ref231","first-page":"7","article-title":"The Current Economic Burden of Cirrhosis","volume":"24","author":"Guy","year":"2011","journal-title":"Gastroenterol"},{"key":"ref171","first-page":"2015","article-title":"Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response","volume":"18","author":"Tachi","journal-title":"Hepatol Res"},{"key":"ref221","first-page":"1","article-title":"Frequent co - occurrence of the TATA box mutation associated with s syndrome with other polymorphisms of the UDPglucuronosyltransferase locus in Caucasians and","volume":"23","author":"K\u00f6hle","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"model to predict survival in patients with end - stage liver disease","author":"Kamath","year":"2001","journal-title":"PS Hepatology"},{"key":"ref31","first-page":"142","article-title":"Hereditary hyperbilirubinemias","author":"Radlovi\u0107","year":"2014"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13016","article-title":"Follow - up of patients with chronic hepatitis and a sustained viral response","volume":"16","author":"Serfaty","year":"2016","journal-title":"Liver Int"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"model to predict survival in patients with end - stage liver disease","author":"Kamath","year":"2001","journal-title":"PS Hepatology"},{"key":"ref281","first-page":"112","article-title":"nekonjugirane hiperbilirubinemije","volume":"29","author":"Jur\u010di\u0107","year":"2006","journal-title":"Paediatr Croat"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmg.12.2.152","article-title":"studies on syndrome","volume":"21","author":"Owens","year":"1975","journal-title":"Population J Med Genet"},{"key":"ref211","first-page":"1","article-title":"Racial variability in the UDP glucuronosyltransferase promoter a balanced polymorphism for regulation of bilirubin metabolism","volume":"22","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10147-013-0562-5","article-title":"Association between severe toxicity of nilotinib and polymorphisms in Japanese patients with chronic myelogenous leukemia","volume":"19","author":"Shibata","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1665-2681(19)31774-0","article-title":"TO syndrome of hepatitis","volume":"8","author":"Deterding","year":"2009","journal-title":"antiviral therapy Ann Hepatol"},{"key":"ref121","first-page":"1","article-title":"de The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase gene hematologic and evolutionary implications","volume":"13","author":"Premawardhena","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref611","first-page":"2015","article-title":"Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response","volume":"18","author":"Tachi","journal-title":"Hepatol Res"},{"key":"ref781","first-page":"827","article-title":"Serum bilirubin levels in the population gender effect and inverse correlation with colorectal cancer","author":"Horn","year":"2004","journal-title":"Zucker PS Hepatology"},{"key":"ref161","article-title":"Excess liver - related morbidity of chronic hepatitis patients who achieve a sustained viral response and are discharged from care","volume":"17","author":"Innes","year":"2011","journal-title":"Hepatology"},{"key":"ref671","first-page":"7","article-title":"The Current Economic Burden of Cirrhosis","volume":"24","author":"Guy","year":"2011","journal-title":"Gastroenterol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3748\/wjg.v13.i3.355","article-title":"Hepatitis virus genotypes in Serbia the prevalence and clinical significance","volume":"15","author":"\u0160virtlih","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmg.12.2.152","article-title":"studies on syndrome","volume":"21","author":"Owens","year":"1975","journal-title":"Population J Med Genet"},{"key":"ref131","first-page":"2015","article-title":"and risk factors for hepatitis virus infection among blood donors in multicentre study Dig","volume":"14","author":"Mitrovi\u0107","journal-title":"Liver Dis"},{"key":"ref601","article-title":"Excess liver - related morbidity of chronic hepatitis patients who achieve a sustained viral response and are discharged from care","volume":"17","author":"Innes","year":"2011","journal-title":"Hepatology"},{"key":"ref301","first-page":"1","article-title":"\u00edkov\u00e1 No association of promoter variations of genes with liver injury in chronic hepatitis","volume":"31","author":"Urb\u00e1nek","year":"2011","journal-title":"Ann Hepatol"},{"key":"ref41","first-page":"1","article-title":"da relationship with abnormal total bilirubin levels in chronic hepatitis patients Outcomes from a case - control study","volume":"11","author":"De Souza","year":"2017","journal-title":"Medicine"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1258\/000456306778520034","article-title":"syndrome an overview for clinical biochemists","volume":"30","author":"Hirschfield","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"ref271","first-page":"405","article-title":"Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium : The Study Viral","volume":"28","author":"Payan","year":"2005"},{"key":"ref81","first-page":"1","article-title":"Effect of the allele on unconjugated hyperbilirubinemia in HIV - positive patients receiving Atazanavir a systematic","volume":"47","author":"Culley","year":"2013","journal-title":"review Ann Pharmacother"},{"key":"ref661","first-page":"1","article-title":"Frequent co - occurrence of the TATA box mutation associated with s syndrome with other polymorphisms of the UDPglucuronosyltransferase locus in Caucasians and","volume":"23","author":"K\u00f6hle","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3748\/wjg.v13.i3.355","article-title":"Hepatitis virus genotypes in Serbia the prevalence and clinical significance","volume":"15","author":"\u0160virtlih","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"31","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/clinchem\/46.6.883","article-title":"staining of denaturing gradient gel electrophoresis","volume":"20","author":"Radojkovi\u0107","year":"2000","journal-title":"gels Clin Chem"},{"key":"ref741","first-page":"1","article-title":"\u00edkov\u00e1 No association of promoter variations of genes with liver injury in chronic hepatitis","volume":"31","author":"Urb\u00e1nek","year":"2011","journal-title":"Ann Hepatol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4254\/wjh.v6.i2.92","article-title":"Association between inherited monogenic liver disorders and chronic hepatitis of","volume":"6","author":"Piekuse","year":"2014","journal-title":"World Journal Hepatology"},{"key":"ref01","first-page":"1","article-title":"of syndrome","volume":"9","author":"Strassburg","year":"2008","journal-title":"Pharmacogenetics Pharmacogenomics"},{"key":"ref511","first-page":"1","article-title":"by is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients One","volume":"8","author":"Wang","year":"2013"},{"key":"ref341","first-page":"827","article-title":"Serum bilirubin levels in the population gender effect and inverse correlation with colorectal cancer","author":"Horn","year":"2004","journal-title":"Zucker PS Hepatology"},{"key":"ref71","first-page":"1","article-title":"by is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients One","volume":"8","author":"Wang","year":"2013"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response Systematic analysis","author":"Simmons","year":"2016","journal-title":"Review Meta Clinical Infectious Diseases"},{"key":"ref311","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/38.9.1853","article-title":"Wagenknecht Sex - and race - related differences in liver - associated serum chemistry tests in young adults in the CARDIA study","volume":"38","author":"Manolio TA","year":"1992","journal-title":"Clin Chem"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1258\/000456306778520034","article-title":"syndrome an overview for clinical biochemists","volume":"30","author":"Hirschfield","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"ref561","first-page":"1","article-title":"de The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase gene hematologic and evolutionary implications","volume":"13","author":"Premawardhena","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref441","first-page":"1","article-title":"of syndrome","volume":"9","author":"Strassburg","year":"2008","journal-title":"Pharmacogenetics Pharmacogenomics"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response Systematic analysis","author":"Simmons","year":"2016","journal-title":"Review Meta Clinical Infectious Diseases"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-2423(10)50003-9","article-title":"Serum bilirubin levels and cardiovascular disease risk a","volume":"50","author":"Franchini","year":"2010","journal-title":"Adv Clin Chem"},{"key":"ref111","first-page":"1","article-title":"glucuronosyltransferase genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age","volume":"12","author":"Tseng","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref551","first-page":"1","article-title":"glucuronosyltransferase genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age","volume":"12","author":"Tseng","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2008.01.004","article-title":"Environmental factors as disease accelerators during chronic hepatitis of","author":"Mallat","year":"2008","journal-title":"Journal Hepatology"}],"container-title":["Journal of Medical Biochemistry"],"original-title":[],"link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/jomb\/38\/1\/article-p45.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2019\/1452-82581901045J.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T16:19:18Z","timestamp":1604247558000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/article.aspx?artid=1452-82581901045J"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":72,"aliases":["10.1515\/jomb-2018-0015"],"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2478\/jomb-2018-0015","relation":{},"ISSN":["1452-8266"],"issn-type":[{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}